Mylan

Also known as Mylan N.V., Mylan Inc., Mylan (United States)

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.

Key facts

Company.name: Mylan N.V.
Company.logo: Mylan Logo.svg
Company.logo_size: 250px
Company.trade_name: Mylan N.V.
Company.former_name: Milan
Company.type: Public
Company.industry: Pharmaceuticals
Company.founded: in White Sulphur Springs, West Virginia, United States
Company.founders: Milan PuskarDon Panoz
Company.fate: Merged with Upjohn to form Viatris
Company.successor: Viatris
Company.hq_location_city: Hatfield, Hertfordshire

~28 min read

Article

36 sections

Contents

Corporate headquarters
Stock
History
Founding to 1980
1980s
Dyazide & Maxzide
Acquisitions begin
1990s
2000s
Attempted King Pharmaceuticals acquisition
Matrix acquisition
EpiPen acquisition
2010s
Generic Advair agreement
EpiPen4Schools launch
Agila acquisition
Abbott acquisition
Attempted Perrigo acquisition
Attempted purchase by Teva
New COPD drug
Meda acquisition
Valsartan recall
Generic Advair approval
Merger with Pfizer's off-patent drug business and name change to Viatris
Stock
Acquisition history
Criticism
EpiPen pricing
Executive pay
Execution drugs
Products
Generic Medicines
Branded Medicines
Management
References
External links

In 2007, the company acquired a controlling interest in India-based Matrix Laboratories Limited, a top producer of active pharmaceutical ingredients (APIs) for generic drugs, and the generics business of Germany-based Merck KGaA. Through these acquisitions, the company grew from the third-largest generic and specialty pharmaceuticals company in the United States to the second-largest generic and specialty pharmaceuticals company in the world.